| The Art and Science of Thyroid Surgery in the Age of Genomics: 100 years after Theodor Kocher | Seza GÜLEÇ | 1–9 |
| Lymph Node Dissection for Differentiated Thyroid Cancer | Avircım MİZRACHİ,Ashok R SHAHA | 10–15 |
| Radioactive Iodine Remnant Ablation: The Beta-knife Completion Thyroidectomy | Seza GÜLEÇ,Russ KUKER | 16–23 |
| Genomic Profiling of Thyroid Nodules: Current Role for ThyroSeq Next-Generation Sequencing on Clinical Decision-Making | Atil Y KARGİ,Marcela Perez BUSTAMANTE,Seza GÜLEÇ | 24–35 |
| Molecular Profiling of Thyroid Nodules: Current Role for the Afirma Gene Expression Classifier on Clinical Decision Making | Richard T KLOOS | 36–49 |
| Nuclear Molecular and Theranostic Imaging for Differentiated Thyroid Cancer | Arif SHEİKH,Berna POLACK,Yvette RODRİGUEZ,Russ KUKER | 50–65 |
| I-124 Imaging and Dosimetry | Russ KUKER,Manuel SZTEJNBERG,Seza GÜLEÇ | 66–73 |
| Diferansiye Tiroid Kanserinde Radyoaktif İyot Tedavisi: Paradigmanın Yeniden Dizaynı | Stanley J. GOLDSMİTH | 74–79 |
| Redifferentiating Thyroid Cancer: Selumetinib-enhanced Radioiodine Uptake in Thyroid Cancer | Steven M LARSON,Joseph R OSBORNE,Ravinder K GREWAL,R Michael TUTTLE | 80–86 |
| Thyroid Stimulating Hormone Receptor | MURAT TUNCEL | 87–91 |
| The Thyroid Na+/I- Symporter: Molecular Characterization and Genomic Regulation | HANİ ALOTAİBİ,MERVE TUZLAKOĞLU ÖZTÜRK,UYGAR HALİS TAZEBAY | 92–101 |
| A Concise Atlas of Thyroid Cancer Next-Generation Sequencing Panel ThyroSeq v.2 | Jorge ALSİNA,Raul ALSİNA,Seza GÜLEÇ | 102–117 |